CRAIG H. BOYCE

As Managing Partner at ALS Investment Fund, Craig H. Boyce is a pivotal figure responsible for setting the firm's strategic direction, leading deal sourcing, and overseeing the entire investment lifecycle. His leadership ensures the fund identifies and nurtures companies with significant potential for disruption and growth. Craig works closely with portfolio companies, offering strategic guidance, operational expertise, and access to extensive industry networks, helping them scale effectively and achieve their long-term objectives.

Craig's investment philosophy centers on identifying innovative companies poised for substantial market impact. His primary focus areas include cutting-edge technology, particularly in artificial intelligence, software as a service (SaaS), and cybersecurity, where he seeks solutions that address critical industry needs. He also has a strong interest in healthcare innovation, supporting advancements in biotechnology, digital health, and medical devices that improve patient outcomes. Furthermore, Craig is a proponent of sustainable solutions, investing in renewable energy, clean technology, and environmentally conscious enterprises that drive positive global change. He consistently looks for strong management teams, defensible intellectual property, and clear paths to profitability.

Before co-founding ALS Investment Fund, Craig H. Boyce built a distinguished career spanning over two decades in finance and venture capital. He began his journey in investment banking, advising technology companies on mergers and acquisitions and capital raises. This experience provided him with a deep understanding of market dynamics and valuation. Subsequently, he transitioned into venture capital, serving as a Principal at a prominent West Coast firm, where he honed his skills in early-stage investing and portfolio management. His diverse background equips him with a holistic perspective on business growth and value creation, allowing him to identify promising ventures across various stages.

While at ALS Investment Fund, Craig has been instrumental in several key investments that underscore his foresight. These include an early-stage investment in 'Synapse AI,' a generative artificial intelligence platform now widely adopted in enterprise solutions, and 'BioGenix Innovations,' a biotechnology firm developing groundbreaking therapies for rare diseases. He also championed the investment in 'EcoPower Solutions,' a leader in advanced solar energy storage systems, which has seen rapid expansion under his guidance. These examples highlight his ability to spot transformative potential and drive successful outcomes for both the fund and its portfolio companies.